0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic Medicine for Infants and Young Children Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-28R18266
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antipyretic Medicine for Infants and Young Children Market Research Report 2024
BUY CHAPTERS

Global Antipyretic Medicine for Infants and Young Children Market Research Report 2024

Code: QYRE-Auto-28R18266
Report
November 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic Medicine for Infants and Young Children Market

Antipyretics are medicines that lower body temperature and relieve fever symptoms. Most antipyretics have other uses. For example, the most common antipyretics in the United States are usually ibuprofen and aspirin, which are nonsteroidal anti-inflammatory drugs that are mainly used as analgesics, but also have antipyretic effects. Because fever is part of the body's immune response, there is some controversy about the use of these drugs. Antipyretics for infants and young children need to be selected and used with extra caution because infants and young children are not yet fully developed and may be more sensitive to the drugs.
The global Antipyretic Medicine for Infants and Young Children market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Antipyretic Medicine for Infants and Young Children is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antipyretic Medicine for Infants and Young Children is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antipyretic Medicine for Infants and Young Children in Online Sales is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antipyretic Medicine for Infants and Young Children include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Medicine for Infants and Young Children, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Medicine for Infants and Young Children.
The Antipyretic Medicine for Infants and Young Children market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antipyretic Medicine for Infants and Young Children market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic Medicine for Infants and Young Children companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antipyretic Medicine for Infants and Young Children Market Report

Report Metric Details
Report Name Antipyretic Medicine for Infants and Young Children Market
Segment by Type
Segment by Application
  • Online Sales
  • Offline Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antipyretic Medicine for Infants and Young Children company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antipyretic Medicine for Infants and Young Children Market report?

Ans: The main players in the Antipyretic Medicine for Infants and Young Children Market are Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang

What are the Application segmentation covered in the Antipyretic Medicine for Infants and Young Children Market report?

Ans: The Applications covered in the Antipyretic Medicine for Infants and Young Children Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Antipyretic Medicine for Infants and Young Children Market report?

Ans: The Types covered in the Antipyretic Medicine for Infants and Young Children Market report are Acetaminophen, Ibuprofen, Other

Recommended Reports

Pediatric Medicines

Children's Supplements

Pediatric Vaccines & Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acetaminophen
1.2.3 Ibuprofen
1.2.4 Other
1.3 Market by Application
1.3.1 Global Antipyretic Medicine for Infants and Young Children Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipyretic Medicine for Infants and Young Children Market Perspective (2019-2030)
2.2 Global Antipyretic Medicine for Infants and Young Children Growth Trends by Region
2.2.1 Global Antipyretic Medicine for Infants and Young Children Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antipyretic Medicine for Infants and Young Children Historic Market Size by Region (2019-2024)
2.2.3 Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Region (2025-2030)
2.3 Antipyretic Medicine for Infants and Young Children Market Dynamics
2.3.1 Antipyretic Medicine for Infants and Young Children Industry Trends
2.3.2 Antipyretic Medicine for Infants and Young Children Market Drivers
2.3.3 Antipyretic Medicine for Infants and Young Children Market Challenges
2.3.4 Antipyretic Medicine for Infants and Young Children Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipyretic Medicine for Infants and Young Children Players by Revenue
3.1.1 Global Top Antipyretic Medicine for Infants and Young Children Players by Revenue (2019-2024)
3.1.2 Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Players (2019-2024)
3.2 Global Antipyretic Medicine for Infants and Young Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antipyretic Medicine for Infants and Young Children Revenue
3.4 Global Antipyretic Medicine for Infants and Young Children Market Concentration Ratio
3.4.1 Global Antipyretic Medicine for Infants and Young Children Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipyretic Medicine for Infants and Young Children Revenue in 2023
3.5 Global Key Players of Antipyretic Medicine for Infants and Young Children Head office and Area Served
3.6 Global Key Players of Antipyretic Medicine for Infants and Young Children, Product and Application
3.7 Global Key Players of Antipyretic Medicine for Infants and Young Children, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipyretic Medicine for Infants and Young Children Breakdown Data by Type
4.1 Global Antipyretic Medicine for Infants and Young Children Historic Market Size by Type (2019-2024)
4.2 Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Type (2025-2030)
5 Antipyretic Medicine for Infants and Young Children Breakdown Data by Application
5.1 Global Antipyretic Medicine for Infants and Young Children Historic Market Size by Application (2019-2024)
5.2 Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antipyretic Medicine for Infants and Young Children Market Size (2019-2030)
6.2 North America Antipyretic Medicine for Infants and Young Children Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024)
6.4 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antipyretic Medicine for Infants and Young Children Market Size (2019-2030)
7.2 Europe Antipyretic Medicine for Infants and Young Children Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024)
7.4 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size (2019-2030)
8.2 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2019-2024)
8.4 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antipyretic Medicine for Infants and Young Children Market Size (2019-2030)
9.2 Latin America Antipyretic Medicine for Infants and Young Children Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024)
9.4 Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size (2019-2030)
10.2 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024)
10.4 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Xinhua Pharmaceutical
11.1.1 Xinhua Pharmaceutical Company Details
11.1.2 Xinhua Pharmaceutical Business Overview
11.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Introduction
11.1.4 Xinhua Pharmaceutical Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.1.5 Xinhua Pharmaceutical Recent Development
11.2 IOLCP
11.2.1 IOLCP Company Details
11.2.2 IOLCP Business Overview
11.2.3 IOLCP Antipyretic Medicine for Infants and Young Children Introduction
11.2.4 IOLCP Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.2.5 IOLCP Recent Development
11.3 Granules Biocause
11.3.1 Granules Biocause Company Details
11.3.2 Granules Biocause Business Overview
11.3.3 Granules Biocause Antipyretic Medicine for Infants and Young Children Introduction
11.3.4 Granules Biocause Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.3.5 Granules Biocause Recent Development
11.4 Strides Shasun
11.4.1 Strides Shasun Company Details
11.4.2 Strides Shasun Business Overview
11.4.3 Strides Shasun Antipyretic Medicine for Infants and Young Children Introduction
11.4.4 Strides Shasun Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.4.5 Strides Shasun Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Details
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Antipyretic Medicine for Infants and Young Children Introduction
11.5.4 Mallinckrodt Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.5.5 Mallinckrodt Recent Development
11.6 Farmson
11.6.1 Farmson Company Details
11.6.2 Farmson Business Overview
11.6.3 Farmson Antipyretic Medicine for Infants and Young Children Introduction
11.6.4 Farmson Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.6.5 Farmson Recent Development
11.7 Granules India
11.7.1 Granules India Company Details
11.7.2 Granules India Business Overview
11.7.3 Granules India Antipyretic Medicine for Infants and Young Children Introduction
11.7.4 Granules India Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.7.5 Granules India Recent Development
11.8 SKPL
11.8.1 SKPL Company Details
11.8.2 SKPL Business Overview
11.8.3 SKPL Antipyretic Medicine for Infants and Young Children Introduction
11.8.4 SKPL Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.8.5 SKPL Recent Development
11.9 Atabay
11.9.1 Atabay Company Details
11.9.2 Atabay Business Overview
11.9.3 Atabay Antipyretic Medicine for Infants and Young Children Introduction
11.9.4 Atabay Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.9.5 Atabay Recent Development
11.10 Temad
11.10.1 Temad Company Details
11.10.2 Temad Business Overview
11.10.3 Temad Antipyretic Medicine for Infants and Young Children Introduction
11.10.4 Temad Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.10.5 Temad Recent Development
11.11 Anqiu Lu'an
11.11.1 Anqiu Lu'an Company Details
11.11.2 Anqiu Lu'an Business Overview
11.11.3 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Introduction
11.11.4 Anqiu Lu'an Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.11.5 Anqiu Lu'an Recent Development
11.12 Zhejiang Kangle
11.12.1 Zhejiang Kangle Company Details
11.12.2 Zhejiang Kangle Business Overview
11.12.3 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Introduction
11.12.4 Zhejiang Kangle Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.12.5 Zhejiang Kangle Recent Development
11.13 Hebei Jiheng
11.13.1 Hebei Jiheng Company Details
11.13.2 Hebei Jiheng Business Overview
11.13.3 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Introduction
11.13.4 Hebei Jiheng Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.13.5 Hebei Jiheng Recent Development
11.14 Novacyl
11.14.1 Novacyl Company Details
11.14.2 Novacyl Business Overview
11.14.3 Novacyl Antipyretic Medicine for Infants and Young Children Introduction
11.14.4 Novacyl Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.14.5 Novacyl Recent Development
11.15 Anhui Fubore
11.15.1 Anhui Fubore Company Details
11.15.2 Anhui Fubore Business Overview
11.15.3 Anhui Fubore Antipyretic Medicine for Infants and Young Children Introduction
11.15.4 Anhui Fubore Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.15.5 Anhui Fubore Recent Development
11.16 Anhui BBCA Likang
11.16.1 Anhui BBCA Likang Company Details
11.16.2 Anhui BBCA Likang Business Overview
11.16.3 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Introduction
11.16.4 Anhui BBCA Likang Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
11.16.5 Anhui BBCA Likang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Acetaminophen
 Table 3. Key Players of Ibuprofen
 Table 4. Key Players of Other
 Table 5. Global Antipyretic Medicine for Infants and Young Children Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2019-2024)
 Table 9. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2025-2030)
 Table 11. Antipyretic Medicine for Infants and Young Children Market Trends
 Table 12. Antipyretic Medicine for Infants and Young Children Market Drivers
 Table 13. Antipyretic Medicine for Infants and Young Children Market Challenges
 Table 14. Antipyretic Medicine for Infants and Young Children Market Restraints
 Table 15. Global Antipyretic Medicine for Infants and Young Children Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Antipyretic Medicine for Infants and Young Children Market Share by Players (2019-2024)
 Table 17. Global Top Antipyretic Medicine for Infants and Young Children Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Medicine for Infants and Young Children as of 2023)
 Table 18. Ranking of Global Top Antipyretic Medicine for Infants and Young Children Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Antipyretic Medicine for Infants and Young Children Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Antipyretic Medicine for Infants and Young Children, Headquarters and Area Served
 Table 21. Global Key Players of Antipyretic Medicine for Infants and Young Children, Product and Application
 Table 22. Global Key Players of Antipyretic Medicine for Infants and Young Children, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2019-2024)
 Table 26. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2025-2030)
 Table 28. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2019-2024)
 Table 30. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2025-2030)
 Table 32. North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Xinhua Pharmaceutical Company Details
 Table 48. Xinhua Pharmaceutical Business Overview
 Table 49. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product
 Table 50. Xinhua Pharmaceutical Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 51. Xinhua Pharmaceutical Recent Development
 Table 52. IOLCP Company Details
 Table 53. IOLCP Business Overview
 Table 54. IOLCP Antipyretic Medicine for Infants and Young Children Product
 Table 55. IOLCP Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 56. IOLCP Recent Development
 Table 57. Granules Biocause Company Details
 Table 58. Granules Biocause Business Overview
 Table 59. Granules Biocause Antipyretic Medicine for Infants and Young Children Product
 Table 60. Granules Biocause Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 61. Granules Biocause Recent Development
 Table 62. Strides Shasun Company Details
 Table 63. Strides Shasun Business Overview
 Table 64. Strides Shasun Antipyretic Medicine for Infants and Young Children Product
 Table 65. Strides Shasun Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 66. Strides Shasun Recent Development
 Table 67. Mallinckrodt Company Details
 Table 68. Mallinckrodt Business Overview
 Table 69. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product
 Table 70. Mallinckrodt Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 71. Mallinckrodt Recent Development
 Table 72. Farmson Company Details
 Table 73. Farmson Business Overview
 Table 74. Farmson Antipyretic Medicine for Infants and Young Children Product
 Table 75. Farmson Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 76. Farmson Recent Development
 Table 77. Granules India Company Details
 Table 78. Granules India Business Overview
 Table 79. Granules India Antipyretic Medicine for Infants and Young Children Product
 Table 80. Granules India Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 81. Granules India Recent Development
 Table 82. SKPL Company Details
 Table 83. SKPL Business Overview
 Table 84. SKPL Antipyretic Medicine for Infants and Young Children Product
 Table 85. SKPL Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 86. SKPL Recent Development
 Table 87. Atabay Company Details
 Table 88. Atabay Business Overview
 Table 89. Atabay Antipyretic Medicine for Infants and Young Children Product
 Table 90. Atabay Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 91. Atabay Recent Development
 Table 92. Temad Company Details
 Table 93. Temad Business Overview
 Table 94. Temad Antipyretic Medicine for Infants and Young Children Product
 Table 95. Temad Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 96. Temad Recent Development
 Table 97. Anqiu Lu'an Company Details
 Table 98. Anqiu Lu'an Business Overview
 Table 99. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product
 Table 100. Anqiu Lu'an Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 101. Anqiu Lu'an Recent Development
 Table 102. Zhejiang Kangle Company Details
 Table 103. Zhejiang Kangle Business Overview
 Table 104. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product
 Table 105. Zhejiang Kangle Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 106. Zhejiang Kangle Recent Development
 Table 107. Hebei Jiheng Company Details
 Table 108. Hebei Jiheng Business Overview
 Table 109. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product
 Table 110. Hebei Jiheng Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 111. Hebei Jiheng Recent Development
 Table 112. Novacyl Company Details
 Table 113. Novacyl Business Overview
 Table 114. Novacyl Antipyretic Medicine for Infants and Young Children Product
 Table 115. Novacyl Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 116. Novacyl Recent Development
 Table 117. Anhui Fubore Company Details
 Table 118. Anhui Fubore Business Overview
 Table 119. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product
 Table 120. Anhui Fubore Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 121. Anhui Fubore Recent Development
 Table 122. Anhui BBCA Likang Company Details
 Table 123. Anhui BBCA Likang Business Overview
 Table 124. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product
 Table 125. Anhui BBCA Likang Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
 Table 126. Anhui BBCA Likang Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Antipyretic Medicine for Infants and Young Children Picture
 Figure 2. Global Antipyretic Medicine for Infants and Young Children Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Antipyretic Medicine for Infants and Young Children Market Share by Type: 2023 VS 2030
 Figure 4. Acetaminophen Features
 Figure 5. Ibuprofen Features
 Figure 6. Other Features
 Figure 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Antipyretic Medicine for Infants and Young Children Market Share by Application: 2023 VS 2030
 Figure 9. Online Sales Case Studies
 Figure 10. Offline Sales Case Studies
 Figure 11. Antipyretic Medicine for Infants and Young Children Report Years Considered
 Figure 12. Global Antipyretic Medicine for Infants and Young Children Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Antipyretic Medicine for Infants and Young Children Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Antipyretic Medicine for Infants and Young Children Market Share by Region: 2023 VS 2030
 Figure 15. Global Antipyretic Medicine for Infants and Young Children Market Share by Players in 2023
 Figure 16. Global Top Antipyretic Medicine for Infants and Young Children Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Medicine for Infants and Young Children as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Antipyretic Medicine for Infants and Young Children Revenue in 2023
 Figure 18. North America Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
 Figure 20. United States Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
 Figure 24. Germany Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share by Region (2019-2030)
 Figure 32. China Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
 Figure 40. Mexico Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
 Figure 44. Turkey Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Xinhua Pharmaceutical Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 48. IOLCP Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 49. Granules Biocause Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 50. Strides Shasun Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 51. Mallinckrodt Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 52. Farmson Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 53. Granules India Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 54. SKPL Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 55. Atabay Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 56. Temad Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 57. Anqiu Lu'an Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 58. Zhejiang Kangle Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 59. Hebei Jiheng Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 60. Novacyl Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 61. Anhui Fubore Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 62. Anhui BBCA Likang Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String